Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
69,631
Sort by:
Global Glaucoma Market Size study, by Indication Type (Open-angle Glaucoma, Angle-closure Glaucoma), by Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonists, Carbonic Anhydrase Inhibitors, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecasts 2022-2032
US$ 3,750.00
Global Glaucoma Market is valued at approximately USD 8.12 billion in 2023 and is anticipated to grow with a healthy compound annual growth rate of more than 11.04% over the forecast period 2024–2032....
May 2025
285 pages
Global Hairy Cell Leukemia Treatment Market Size study, by Therapy (Chemotherapy, Targeted Therapy, Immunotherapy), Gender (Male, Female), Treatment Providers (Hospitals & Clinics, Cancer Care Center, Academic & Research Institutes), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Hairy Cell Leukemia Treatment Market is valued approximately at USD 0.13 billion in 2023 and is projected to exhibit a steady compound annual growth rate of more than 6.50% over the forecas...
May 2025
285 pages
Global Hydroxyzine Market Size study, by Dosage Form (Tablets, Capsules, Injections, Syrups), Route of Administration (Oral, Intramuscular), Indication (Urticaria, Atopic Contact Dermatitis, Histamine-mediated Pruritus), Distribution Channel and Regional Forecasts 2022-2032
US$ 3,750.00
Global Hydroxyzine Market is valued approximately at USD 0.78 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.40% over the forecast period 2024-2032. Hydroxyzine,...
May 2025
285 pages
Global Immune Checkpoint Inhibitors Market Size study, by Type (PD-1, PD-L1, CTLA-4), Application (Lung Cancer, Breast Cancer, Bladder Cancer, Melanoma, Cervical Cancer), End-use (Hospitals & Clinics, Cancer Centers), and Regional Forecasts 2022-2032
US$ 3,750.00
Global Immune Checkpoint Inhibitors Market is valued approximately at USD 40.62 billion in 2023 and is anticipated to grow with an impressive compound annual growth rate of more than 16.70% over the f...
May 2025
285 pages
Global Influenza Medications Market Size study, by Drug Type (Antiviral [Single, Combination], Antihistamines), by Influenza Type (A, B), by Age Group, by Route of Administration (Oral, Inhaled), by Type (Branded, Generic), by Medication, by Distribution Channel and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Influenza Medications Market was valued at approximately USD 0.94 billion in 2023 and is expected to expand at a steady compound annual growth rate (CAGR) of 2.90% throughout the forecast p...
May 2025
285 pages
Global Lidocaine Hydrochloride Market Size study, by Dosage Form (Creams, Patches, Injectables), Application (Cardiology, Dental, Epilepsy, Dermatological), Product Type (Generics, Branded), End-user (Hospitals, Clinics, ASCs), and Regional Forecasts 2022-2032
US$ 3,750.00
Global Lidocaine Hydrochloride Market is valued approximately at USD 0.75 billion in 2023 and is expected to expand at a compelling compound annual growth rate (CAGR) of 5.50% over the forecast period...
May 2025
285 pages
Global Lipid Regulators Market Size study, by Type (Statins [Branded, Combination], Non-statins [Fibric-acid Derivatives, Bile-acid]), by Indication (Hypercholesterolemia, Coronary Artery Disease), Route of Administration, Distribution Channel, and Regional Forecasts 2022-2032
US$ 3,750.00
Global Lipid Regulators Market is valued approximately at USD 32.4 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3.80% over the forecast period 2024–2032. Lipid re...
May 2025
285 pages
Global Loratadine Market Size study, by Type (Oral, Topical), Dosage Form (Tablets, Syrups, Creams, Gels), Strength (5 mg, 10 mg), Application (Seasonal Allergic Rhinitis, Chronic Urticaria) and Regional Forecasts 2022-2032
US$ 3,750.00
Global Loratadine Market is valued approximately at USD 0.17 billion in 2023 and is anticipated to grow with a moderate growth rate of more than 3.67% over the forecast period 2024-2032. Loratadine, a...
May 2025
285 pages
Global Multiple Sclerosis Therapeutic Market Size study, by Drug Class (Immunosuppressants, Immunostimulants, Immunomodulators), Route of Administration (Oral, Injectable [Intramuscular, Intravenous]), Distribution Channel (Hospital, Retail, Online), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Multiple Sclerosis Therapeutic Market is valued at approximately USD 25.5 billion in 2023 and is projected to grow at a healthy compound annual growth rate of more than 4.70% over the forec...
May 2025
285 pages
Global Myelodysplastic Syndrome Drugs Market Size study, by Drug Type (Hypomethylating, Immune Therapy, Anti-anaemics), Route of Administration (Oral, Parenteral), Medication (Branded, Generic), Cancer Type, Age Group, End-user, and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Myelodysplastic Syndrome (MDS) Drugs Market is valued at approximately USD 2.8 billion in 2023 and is expected to register a robust compound annual growth rate of more than 8.00% over the f...
May 2025
285 pages
Global Naltrexone and Buprenorphine Market Size study, by Product Type (Naltrexone, Buprenorphine, Combination Therapies), by Formulation (Tablets, Injections, Sublingual Films, Extended-Release Solutions), by Indication (Opiate Addiction, Alcohol Dependence, Chronic Pain Management), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2022-2032
US$ 3,750.00
Global Naltrexone and Buprenorphine Market is valued approximately at USD 3.74 billion in 2023 and is anticipated to grow with a promising compound annual growth rate of more than 6.99% over the forec...
May 2025
285 pages
Global Non-Injectable Insulin Market Size study, by Product Type (Insulin Patches, Insulin Inhalers, Insulin Pens, Insulin Gels), by Therapeutic Area (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by End User (Hospitals, Home Care Settings, Diabetes Clinics), and Regional Forecasts 2022-2032
US$ 3,750.00
Global Non-Injectable Insulin Market is valued approximately at USD 8.04 billion in 2023 and is anticipated to grow with a steady growth rate of more than 5.67% over the forecast period 2024–2032. As...
May 2025
285 pages
Global Postpartum Health Supplements Market Size study, by Product Type (Single Nutritional [Vitamins, Protein, Omega-3], Combined Nutritional), by Formulation (Capsules, Tablets, Softgels, Liquid), by Distribution Channel (Hospital, Retail, Online) and Regional Forecasts 2022-2032
US$ 3,750.00
Global Postpartum Health Supplements Market is valued approximately at USD 1.2 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.00% over the forecast period 2024-20...
May 2025
285 pages
Global Scopolamine Market Size study, by Dosage Form (Transdermal Patches, Tablets, Injectables), by Application (Motion Sickness, Postoperative Nausea and Vomiting), by Route of Administration (Topical, Oral, Parenteral), Distribution Channel and Regional Forecasts 2022-2032
US$ 3,750.00
Global Scopolamine Market is valued approximately at USD 0.41 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.30% over the forecast period 2024-2032. Scopolamine,...
May 2025
285 pages
